Clinical trial • Enrolling • 19 February 2010
The Evaluation of the Impacts of a Doctor – Pharmacist Collaborative Prescribing Model on the Management of Human Immunodeficiency Virus (HIV) Infected Patients
Tags: Accessing HIV care and treatment
Clinical trial • Enrolling • 19 February 2010
A prospective cohort study of individuals with primary Human Immunodefiency Virus (HIV) infection to determine immunological and virological factors related to disease progression.
Tags: pathogenesis
Clinical trial • Enrolling • 19 February 2010
A Randomized Open Label Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Amantadine and Ribavirin With Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects
Clinical trial • Unknown • 19 February 2010
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
Tags: hepatitis B
Clinical trial • Reported • 17 February 2010
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
Clinical trial • Unknown • 17 February 2010
Evaluation of Interferon-Gamma Responses to HCMV Infection in HIV Positive Individuals
Tags: CMV
Clinical trial • Concluded • 17 February 2010
A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase
Tags: drug resistance, NRTI
Clinical trial • Enrolling • 22 January 2010
Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
Clinical trial • Enrolling • 21 August 2009
A Randomised, Open-Label, Cross-Over Study to Examine the Pharmacokinetics and Short-Term Safety and Efficacy of Two Dosing Strategies of Raltegravir Plus Atazanavir in HIV-Infected Patients
Tags: atazanavir, first-line therapy, raltegravir
Clinical trial • Enrolling • 9 April 2009
Strategic Timing of AntiRetroviral Treatment (START)
Tags: starting treatments
Clinical trial • No longer enrolling • 8 April 2009
A Phase II multicenter, open-label,
randomized, parallel group, study of
bevirimat (MPC-4326) in HIV-1 positive patients to evaluate the safety, efficacy, and pharmacokinetics of bevirimat administered as monotherapy for 14 days and as part of an optimized background regimen for
up to 72 weeks.
Tags: Bevirimat
Clinical trial • No longer enrolling • 8 April 2009
Cardiovascular function with switching from Kivexa to Truvada (or from Abacavir to Tenofovir) in people with Human Immunodeficiency Virus (HIV).
Tags: heart disease
Clinical trial • Fully enrolled • 8 April 2009
A one-year, open label, extension study of flupirtine for the treatment of painful HIV-sensory neuropathy in patients who have pain inadequately controlled by opioids
Tags: peripheral neuropathy
Clinical trial • Enrolling • 24 March 2009
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
This site complies with the HONcode standard for trustworthy health information: verify here.